| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6138348 | Trends in Parasitology | 2007 | 4 Pages |
Abstract
An important chapter in the search for a vaccine against malaria, that of the anti-Plasmodium falciparum vaccine candidate SPf66, has been effectively closed. A Cochrane review of ten major efficacy trials in endemic areas concluded it 'has little or no effect on preventing malaria'. This provides an appropriate opportunity to reflect on the perspectives for current and future vaccine formulations against Plasmodium.
Related Topics
Life Sciences
Immunology and Microbiology
Parasitology
Authors
Georges Snounou, Laurent Rénia,